| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Medicine and
Pathology, University of Washington, Seattle, WA 98195; and
Department of Immunology, Immunex Research and Development Corporation, Seattle, WA 98101
In vitro and in vivo studies, in both animal models and human asthmatics, have implicated IL-4 as an important inflammatory mediator in asthma. In a murine asthma model, we examined the anti-inflammatory activities of soluble IL-4R (sIL-4R). In this model, mice sensitized to OVA by i.p. and intranasal (i.n.) routes are challenged with the allergen by i.n. administration. The OVA challenge elicits an eosinophil infiltration into the lungs, with widespread mucus occlusion of the airways, and results in bronchial hyperreactivity. sIL-4R (0.1–100 µg) was administered by either i.n. or i.p. routes before OVA challenge in OVA-sensitized mice. Both blood and bronchoalveolar lavage fluid levels of sIL-4R were significantly elevated compared with controls by i.n. delivery of 100 µg sIL-4R; i.p. delivery of 100 µg sIL-4R only raised blood levels of sIL-4R. The i.n. administration of 100 µg sIL-4R before allergen challenge significantly reduced late phase pulmonary inflammation, blocking airway eosinophil infiltration, VCAM-1 expression, and mucus hypersecretion. In contrast, i.p. delivery of 100 µg sIL-4R inhibited only the influx of eosinophils into the lungs, but not airway mucus release. Furthermore, sIL-4R treatment by either i.n. or i.p. routes did not reduce airway hyperreactivity in response to methacholine challenge. Thus, elevating airway levels of sIL-4R through the administration of exogenous sIL-4R is effective in blocking the late phase pulmonary inflammation that occurs in this murine allergen-challenge asthma model. These results suggest that sIL-4R may have beneficial anti-inflammatory effects in asthmatic patients.
This article has been cited by other articles:
|
|
 |
|
  M. Okamoto, H. Matsuda, A. Joetham, J. J. Lucas, J. Domenico, K. Yasutomo, K. Takeda, and E. W. Gelfand Jagged1 on Dendritic Cells and Notch on CD4+ T Cells Initiate Lung Allergic Responsiveness by Inducing IL-4 Production J. Immunol., September 1, 2009; 183(5): 2995 - 3003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Nials and S. Uddin Mouse models of allergic asthma: acute and chronic allergen challenge Dis. Model. Mech., November 1, 2008; 1(4-5): 213 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-H. Ning, E. Y. Chi, N. E. Buroker, S.-H. Chen, C.-S. Xu, Y.-T. Tien, O. M. Hyyti, M. Ge, and M. A. Portman Moderate hypothermia (30{degrees}C) maintains myocardial integrity and modifies response of cell survival proteins after reperfusion Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2119 - H2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Koya, N. Miyahara, K. Takeda, S. Matsubara, H. Matsuda, C. Swasey, A. Balhorn, A. Dakhama, and E. W. Gelfand CD8+ T Cell-Mediated Airway Hyperresponsiveness and Inflammation Is Dependent on CD4+IL-4+ T Cells J. Immunol., September 1, 2007; 179(5): 2787 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. T. McCusker, Y. Wang, J. Shan, M. W. Kinyanjui, A. Villeneuve, H. Michael, and E. D. Fixman Inhibition of Experimental Allergic Airways Disease by Local Application of a Cell-Penetrating Dominant-Negative STAT-6 Peptide J. Immunol., August 15, 2007; 179(4): 2556 - 2564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-W. Xia, W.-W. Zhong, L.-Q. Xu, J.-L. Sun, Q.-X. Shen, J.-G. Wang, J. Shao, Y.-Z. Li, and S.-C. Yu Heme Oxygenase-1-Mediated CD4+CD25high Regulatory T Cells Suppress Allergic Airway Inflammation J. Immunol., November 1, 2006; 177(9): 5936 - 5945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bergeron and L.-P. Boulet Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest, April 1, 2006; 129(4): 1068 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Henderson Jr., G. K. S. Chiang, Y.-t. Tien, and E. Y. Chi Reversal of Allergen-induced Airway Remodeling by CysLT1 Receptor Blockade Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 718 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hoshino, T. Tsuji, J. Matsuzaki, T. Jinushi, S. Ashino, T. Teramura, K. Chamoto, Y. Tanaka, Y. Asakura, T. Sakurai, et al. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation Int. Immunol., October 1, 2004; 16(10): 1497 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.E. Christie, M. Jonas, C-H. Tsai, E.Y. Chi, and W.R. Henderson Jr Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone Eur. Respir. J., July 1, 2004; 24(1): 107 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Eisenbarth, A. Zhadkevich, P. Ranney, C. A. Herrick, and K. Bottomly IL-4-Dependent Th2 Collateral Priming to Inhaled Antigens Independent of Toll-Like Receptor 4 and Myeloid Differentiation Factor 88 J. Immunol., April 1, 2004; 172(7): 4527 - 4534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Webb, K. I. Matthaei, Y. Cai, A. N. J. McKenzie, and P. S. Foster Polymorphisms in IL-4R{alpha} Correlate with Airways Hyperreactivity, Eosinophilia, and Ym Protein Expression in Allergic IL-13-/- Mice J. Immunol., January 15, 2004; 172(2): 1092 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chvatchko, A. E. I. Proudfoot, R. Buser, P. Juillard, S. Alouani, M. Kosco-Vilbois, A. J. Coyle, R. J. Nibbs, G. Graham, R. E. Offord, et al. Inhibition of Airway Inflammation by Amino-Terminally Modified RANTES/CC Chemokine Ligand 5 Analogues Is Not Mediated through CCR3 J. Immunol., November 15, 2003; 171(10): 5498 - 5506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Raman, M. H. Kaplan, C. M. Hogaboam, A. Berlin, and N. W. Lukacs STAT4 Signal Pathways Regulate Inflammation and Airway Physiology Changes in Allergic Airway Inflammation Locally Via Alteration of Chemokines J. Immunol., April 1, 2003; 170(7): 3859 - 3865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. H. Shen, S. I. Ochkur, M. P. McGarry, J. R. Crosby, E. M. Hines, M. T. Borchers, H. Wang, T. L. Biechelle, K. R. O'Neill, T. L. Ansay, et al. A Causative Relationship Exists Between Eosinophils and the Development of Allergic Pulmonary Pathologies in the Mouse J. Immunol., March 15, 2003; 170(6): 3296 - 3305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iwata, K. Nishio, R. K. Winn, E. Y. Chi, W. R. Henderson Jr., and J. M. Harlan A Broad-Spectrum Caspase Inhibitor Attenuates Allergic Airway Inflammation in Murine Asthma Model J. Immunol., March 15, 2003; 170(6): 3386 - 3391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Y. Larbi, J. P. Dangerfield, F. J. Culley, D. Marshall, D. O. Haskard, P. J. Jose, T. J. Williams, and S. Nourshargh P-selectin mediates IL-13-induced eosinophil transmigration but not eotaxin generation in vivo: a comparative study with IL-4-elicited responses J. Leukoc. Biol., January 1, 2003; 73(1): 65 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Taube, C. Duez, Z.-H. Cui, K. Takeda, Y.-H. Rha, J.-W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand The Role of IL-13 in Established Allergic Airway Disease J. Immunol., December 1, 2002; 169(11): 6482 - 6489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Henderson Jr., E. Y. Chi, J.-L. Teo, C. Nguyen, and M. Kahn A Small Molecule Inhibitor of Redox-Regulated NF-{kappa}B and Activator Protein-1 Transcription Blocks Allergic Airway Inflammation in a Mouse Asthma Model J. Immunol., November 1, 2002; 169(9): 5294 - 5299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Moreland, R. M. Fuhrman, J. A. Pruessner, and D. A. Schwartz CD11b and Intercellular Adhesion Molecule-1 Are Involved in Pulmonary Neutrophil Recruitment in Lipopolysaccharide-Induced Airway Disease Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 474 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-W. Oh, C. I. Pae, D.-K. Lee, F. Jones, G. K. S. Chiang, H.-O. Kim, S.-H. Moon, B. Cao, C. Ogbu, K.-W. Jeong, et al. Tryptase Inhibition Blocks Airway Inflammation in a Mouse Asthma Model J. Immunol., February 15, 2002; 168(4): 1992 - 2000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Perez-G., M. Melo, A. D. Keegan, and J. Zamorano Aspirin and Salicylates Inhibit the IL-4- and IL-13-Induced Activation of STAT6 J. Immunol., February 1, 2002; 168(3): 1428 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Chapoval, K. Iijima, E. V. Marietta, M. K. Smart, A. I. Chapoval, A. G. Andrews, and C. S. David Allergic Inflammatory Response to Short Ragweed Allergenic Extract in HLA-DQ Transgenic Mice Lacking CD4 Gene J. Immunol., January 15, 2002; 168(2): 890 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. HENDERSON JR., L.-O. TANG, S.-J. CHU, S.-M. TSAO, G. K. S. CHIANG, F. JONES, M. JONAS, C. PAE, H. WANG, and E. Y. CHI A Role for Cysteinyl Leukotrienes in Airway Remodeling in a Mouse Asthma Model Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 108 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Takaoka, Y. Tanaka, T. Tsuji, T. Jinushi, A. Hoshino, Y. Asakura, Y. Mita, K. Watanabe, S. Nakaike, Y. Togashi, et al. A Critical Role for Mouse CXC Chemokine(s) in Pulmonary Neutrophilia During Th Type 1-Dependent Airway Inflammation J. Immunol., August 15, 2001; 167(4): 2349 - 2353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tomkinson, C. Duez, G. Cieslewicz, J. C. Pratt, A. Joetham, M.-C. Shanafelt, R. Gundel, and E. W. Gelfand A Murine IL-4 Receptor Antagonist That Inhibits IL-4- and IL-13-Induced Responses Prevents Antigen-Induced Airway Eosinophilia and Airway Hyperresponsiveness J. Immunol., May 1, 2001; 166(9): 5792 - 5800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cianferoni, J. T. Schroeder, J. Kim, J. W. Schmidt, L. M. Lichtenstein, S. N. Georas, and V. Casolaro Selective inhibition of interleukin-4 gene expression in human T cells by aspirin Blood, March 15, 2001; 97(6): 1742 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.C. Kips, K.G. Tournoy, and R.A. Pauwels New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5 Eur. Respir. J., March 1, 2001; 17(3): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Justice, J. Crosby, M. T. Borchers, A. Tomkinson, J. J. Lee, and N. A. Lee CD4+ T cell-dependent airway mucus production occurs in response to IL-5 expression in lung Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L1066 - L1074. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
